Arietta.ai offers an AI-powered platform that automates adverse event intake and triage for life sciences companies. Its LLM-based solution and proprietary Extraction and Classification Engine streamline pharmacovigilance workflows, accelerating case processing and improving data insights.
Funding
Funding not disclosed
Founders
Product
Problem
Life sciences companies face significant challenges in processing and analyzing the increasing volume of communications, which can delay critical medical decision-making and data insights. Existing workflows for adverse event intake and triage are often resource-intensive and time-consuming, impacting operational efficiency and drug safety processes.
Solution
Arietta.ai provides an AI-powered platform, LucidPV, designed to accelerate and streamline the processing of communications for life sciences organizations. The platform leverages advanced Large Language Models (LLMs) and a proprietary Extraction and Classification Engine (XCE) to automate adverse event intake and triage. This enhances case-processing productivity by delivering scalable, compliant, and efficient operations. LucidPV augments existing workflows, providing immediate time savings and improving the accuracy of pharmacovigilance processes. The continuous learning architecture ensures that performance and time savings increase over time, driving drug safety into a new era.
Target Audience
The primary customers are life sciences companies, including pharmaceutical and biotechnology firms, that require enhanced efficiency and accuracy in their pharmacovigilance and adverse event management processes.
Features
- LLM-based platform for adverse event intake and triage, automating initial case processing.
- Proprietary Extraction and Classification Engine (XCE) utilizing purpose-built and trained models for superior data extraction and classification.
- Continuous learning architecture that enhances model performance and accuracy over time.
- Scalable and compliant solution designed to integrate with and augment existing pharmacovigilance workflows.
- Focus on accelerating medical decision-making and data insights through efficient communication analysis.
- Tools designed to enhance the capabilities of medical experts without replacement.